ImmunoPterin A Breakthrough Discover for the Immune System Subscribe to our Newsletter
social media links Visit Our Facebook Page Dr. Phillip Moheno PhD
Home About Product Overview Success Stories News/Events Contact Us Shop

About ImmunoPterin


Background


Based in San Diego, California, SanRx is the leading developer of immune-supporting compounds based on the naturally-occurring human small molecule "pterin." Preclinical testing by reputable third-party laboratories substantiates that the compounds discovered by SanRx provide a strong potential to support the human immune system against a number of immune imbalance conditions without the side effects or high cost of traditional therapies. For more information, visit sanrx.com.

Leadership

Phillip B.B. Moheno, PhD, Founder, President, and Chief Scientist


hillip Moheno, PhDSince the 1970's, Dr. Moheno has been involved in research that led to the development of proprietary anti-cancer and immune-boosting compounds at institutions including the Salk Institute for Biological Studies, the La Jolla Cancer Research Foundation, the University of California Los Angeles (where he was a Ford Foundation Fellow in Biochemistry), the California State Universities of Bakersfield and San Diego, San Diego Research and SanRx.

Moheno holds a BS and a Candidate in Philosophy in Biochemistry from the University of California, Los Angeles, and a PhD in Confluent Education from the University of California, Santa Barbara. In addition to more than 20 years of research experience into the anti-cancer properties of pterins, Moheno has more than seven years' experience as Vice President of Intellectual Property and Partnerships for Verne Mendel Medical Corp. and as Chief Executive Officer and Principal Investigator for San Diego Research.

Dr. Moheno's research and development activities in cancer pharmacology have led to the awarding of over 20 patents, with additional applications in process. Moheno also has over 15 years of experience as an undergraduate professor in biochemistry and biology, most recently as adjunct professor of chemistry at California State University, San Marcos.

Edgar Berkey, PhD, Founder, Chief Executive Officer and Board Chair


Edgar BerkeyPrevious experience: Vice President, Research and Development, and Chief Quality Officer of Concurrent Technologies Corporation, a large national applied research organization in the energy, environmental, and national defense fields; President and Co-Founder of the Center for Hazardous Materials Research, and the National Environmental Technology Applications Corporation in Pittsburgh, PA; founder and President of SynCo Consultants, Inc., Vice President of Energy Impact Associates; Manager and Senior Research Scientist at Westinghouse Research Laboratories; education includes a PhD in engineering physics from Cornell, a BS in chemical engineering from Stanford, and the Executive MBA Program at the University of Pittsburgh.

Timeline of Discovery »

The SanRx Scientific Advisory Board
SanRx

Boris Minev
Dr. Boris Minev
MD Head of Tumor Immunology and Research Scientist, UCSD Cancer Center


Dr. Minev has done significant work in the field of tumor immunology and immunotherapy, and development of synthetic and recombinant vaccines for cancer, including new approaches to immunotherapy of breast and prostate cancer and melanoma.

Ewa Carrier, MD
Dr. Ewa Carrier
Associate Professor, Medicine & Hematologic Malignancies, UCSD Cancer Center

Dr. Carrier's research focuses on stem cell biology and its transplantation to cancer and organ repair, She focuses on the properties of pluripotent stem cells, including embryonic, fetal, mesenchymal and bone marrow stem cells, to generate differentiation protocols for the treatment of a variety of disorders.

Dietmar Fuchs, PhD
Associate Professor of Medical Chemistry, Innsbruck Medical University, Austria

Dr Fuchs is co-director of the Ludwig Boltzmann Institute of AIDS-Research in Innsbruck and holds a PhD in Chemistry from the Leopold Franzens University of Innsbruck. Dr Fuchs has authored over 100 publications in the field of clinical immunology addressing key immune imbalance areas such as cancer, AIDS and Alzheimer's. He is an executive member of the International Society of Pteridinology.

Wolfgang Pfleiderer, PhD
Professor of Chemistry, Universities of Stuttgart and Konstanz in Germany

Professor Pfleiderer has over 50 years of experience in academia, and is considered a world renowned expert in pteridine and heterocyclic chemistry. Professor Pfleiderer is President of the International Societies of Heterocyclic Chemistry, Pteridinology and Nucleic Acid Research.

SanRx Scientific and Business Advisory Team:

Christiana Winkler, PhD - Innsbruck Medical University (Austria), Medical Chemistry
Arnold L. Rheingold, PhD - UC San Diego, Chemistry & Biochemistry
Antonio G. DiPasquale, PhD - UC Berkeley College of Chemistry
James C. Ryan, MD - UC San Francisco, Immunology
Grant Ferrier - Founder, Nutrition Capital Network
Jeff Teza – Principal, JT Capital
Cynthia Jones – Principal, Jones & Taylor Communications
Vincent Gammill, ScD - Director, Center for the Study of Natural Oncology
Paul Rangel, Distribution

These statements have not been evaluated by the Food and Drug Administration. This product is intended for overall immune system support and not to diagnose, treat, cure or prevent any disease. If seeking treatment for a specific disease, consult your health practitioner.


Home
| Product Overview | Success Stories | News/Events | Contact Us | Shop | Policies
©ImmunoPterin™. All Rights Reserved.